Ares Management Corporation · ARES · FY2024 Q2 · Calendar Q3 2024
Ares: Record fundraising supports deployment across credit and infrastructure
The current and prior analyses support a constructive but conditional view: fundraising, alternative-asset demand, private-credit deployment, infrastructure investment, and expanding wealth distribution provide growth support, while credit quality, rates, competition, regulation, and M&A activity remain important constraints.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about ARES FY2024 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior-quarter analysis, the current analysis emphasizes record fundraising, stronger net deployment, broader international wealth-management flows, and larger digital, data-center, and climate-infrastructure ambitions. The growth story remains broadening beyond private credit, with new specialty-fund activity and selective M&A under consideration.
Guidance delta
Management guidance sentiment was maintained; management remained optimistic about a productive second half despite macro volatility.
Key takeaways
- The current analysis describes record fundraising and continued AUM growth as the foundation for deployment.
- Private-credit deployment strengthened, with a robust pipeline and activity across direct lending and related platforms.
- Digital, data-center, climate-infrastructure, real-estate, insurance, and wealth-management initiatives remain central to the growth narrative.
- International wealth-management distribution is expanding, while management is considering selective inorganic growth.
Management priorities
- Advance private-credit and real-assets deployment.
- Expand digital-infrastructure, data-center, and clean-energy investments.
- Broaden wealth-management distribution and specialty-fund offerings.
- Pursue selective inorganic growth in insurance and infrastructure.
Follow ARES with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 19, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Oct 13, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 12, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 27, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 3, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 3, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Aug 3, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 9, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 9, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Apr 21, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 7, 2026 |
| Raymond James | Strong Buy | Market Perform | Upgrade | Feb 9, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Feb 9, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Nov 4, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 3, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Aug 6, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 11, 2025 |
| Jefferies | Hold | Hold | Maintain | May 9, 2024 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 13, 2023 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Nov 25, 2020 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Nov 25, 2020 |
| Credit Suisse | Outperform | Neutral | Upgrade | Nov 25, 2020 |
| Bank of America | Buy | Neutral | Upgrade | Nov 25, 2020 |
Named analyst price targets
Upside is calculated against the persisted current price $112.27. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $149 | $114.65 | +32.7% | Oct 16, 2026 |
| Wells Fargo | Daniel Welden | $136 | $116.57 | +21.1% | Oct 1, 2026 |
| Piper Sandler | Crispin Love | $150 | $121.48 | +33.6% | Sep 24, 2026 |
| RBC Capital | Bart Dziarski | $168 | $134.39 | +49.6% | Aug 3, 2026 |
| Deutsche Bank | Analyst unavailable | $144 | $135.01 | +28.3% | Aug 3, 2026 |
| Oppenheimer | Analyst unavailable | $151 | $133.2 | +34.5% | Aug 3, 2026 |
| BMO Capital | Brennan Hawken | $134 | $128.09 | +19.4% | Aug 3, 2026 |
| Morgan Stanley | Analyst unavailable | $160 | $121.14 | +42.5% | Jul 21, 2026 |
| BMO Capital | Analyst unavailable | $128 | $122.06 | +14.0% | Jul 13, 2026 |
| Barclays | Analyst unavailable | $139 | $120.29 | +23.8% | Jul 9, 2026 |
| Barclays | Analyst unavailable | $140 | $119.06 | +24.7% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $163 | $122.32 | +45.2% | Apr 21, 2026 |
| RBC Capital | Bart Dziarski | $173 | $115.94 | +54.1% | Feb 24, 2026 |
| UBS | Analyst unavailable | $148 | $128.16 | +31.8% | Feb 20, 2026 |
| RBC Capital | Analyst unavailable | $180 | $135.12 | +60.3% | Feb 9, 2026 |
| Oppenheimer | Analyst unavailable | $215 | $128.94 | +91.5% | Feb 6, 2026 |
| Goldman Sachs | Analyst unavailable | $165 | $128.7 | +47.0% | Feb 6, 2026 |
| Barclays | Analyst unavailable | $190 | $121.87 | +69.2% | Feb 6, 2026 |
| Deutsche Bank | Brian Bedell | $155 | $121.87 | +38.1% | Feb 6, 2026 |
| Morgan Stanley | Analyst unavailable | $178 | $149.69 | +58.5% | Jan 27, 2026 |
| Oppenheimer | Analyst unavailable | $224 | $167.03 | +99.5% | Jan 20, 2026 |
| UBS | Analyst unavailable | $198 | $169.5 | +76.4% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $222 | $175.75 | +97.7% | Jan 9, 2026 |
| Wolfe Research | Analyst unavailable | $210 | $172.84 | +87.0% | Jan 7, 2026 |
| Barclays | Analyst unavailable | $218 | $176.82 | +94.2% | Dec 12, 2025 |
| UBS | Michael Brown | $201 | $178.3 | +79.0% | Dec 11, 2025 |
| Oppenheimer | Chris Kotowski | $190 | $153.75 | +69.2% | Nov 4, 2025 |
| Morgan Stanley | Analyst unavailable | $175 | $149.21 | +55.9% | Oct 21, 2025 |
| Oppenheimer | Analyst unavailable | $180 | $143.63 | +60.3% | Oct 14, 2025 |
| Barclays | Analyst unavailable | $187 | $148.64 | +66.6% | Oct 8, 2025 |
| JMP Securities | Brian McKenna | $195 | $180.34 | +73.7% | Jul 14, 2025 |
| Wolfe Research | Steven Chubak | $193 | $159.63 | +71.9% | May 6, 2025 |
| Barclays | Benjamin Budish | $182 | $160.96 | +62.1% | May 6, 2025 |
| Wolfe Research | Steven Chubak | $218 | $180.87 | +94.2% | Jan 3, 2025 |
| RBC Capital | Kenneth Lee | $205 | $176.11 | +82.6% | Dec 10, 2024 |
| RBC Capital | Kenneth Lee | $170 | $157.81 | +51.4% | Oct 11, 2024 |
| Morgan Stanley | Michael Cyprys | $162 | $156.95 | +44.3% | Oct 10, 2024 |
| Barclays | Benjamin Budish | $174 | $160.39 | +55.0% | Oct 7, 2024 |
| CFRA | Kenneth Leon | $170 | $156.38 | +51.4% | Sep 23, 2024 |
| Wells Fargo | Michael Brown | $156 | $141.46 | +39.0% | Sep 11, 2024 |
| Redburn Partners | Nicholas Watts | $140 | $146.96 | +24.7% | Aug 27, 2024 |
| Barclays | Benjamin Budish | $155 | $139.26 | +38.1% | Aug 5, 2024 |
| CFRA | Kenneth Leon | $155 | $139.26 | +38.1% | Aug 2, 2024 |
| Barclays | Benjamin Budish | $151 | $134.78 | +34.5% | Jul 10, 2024 |
| Deutsche Bank | Brian Bedell | $132 | $137.49 | +17.6% | Jun 13, 2024 |
| Deutsche Bank | Brian Bedell | $176 | $146.7 | +56.8% | May 28, 2024 |
| UBS | Brent Dilts | $160 | $146.31 | +42.5% | May 22, 2024 |
| RBC Capital | Kenneth Lee | $150 | $136.17 | +33.6% | May 7, 2024 |
| Barclays | Benjamin Budish | $150 | $134.64 | +33.6% | May 3, 2024 |
| Barclays | Analyst unavailable | $87 | $75.1 | -22.5% | Jan 12, 2023 |
| Barclays | Analyst unavailable | $82 | $68.14 | -27.0% | Dec 19, 2022 |
| UBS | Analyst unavailable | $95 | $79.53 | -15.4% | Nov 15, 2022 |
| BMO Capital | Analyst unavailable | $87 | $68.79 | -22.5% | Apr 29, 2022 |
| Morgan Stanley | Analyst unavailable | $90 | $81.94 | -19.8% | Apr 20, 2022 |
| Wells Fargo | Analyst unavailable | $92 | $79.71 | -18.1% | Apr 19, 2022 |
| Barclays | Jeremy Campbell | $62 | $53.55 | -44.8% | Apr 12, 2021 |
Track every rating change on ARES the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAres Management Corporation functions as an investment firm specializing in alternative assets, with operations spanning the United States, Europe, and Asia. Its Tradable Credit division oversees diverse investment vehicles, including pooled funds and separately managed accounts for institutional investors, alongside publicly traded products and sub-advised funds aimed at retail investors, all within the tradable and non-investment grade corporate credit markets. The Direct Lending segment delivers financial solutions to small and medium-sized businesses.…
Historical context
All ARES earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| IBN ICICI Bank Limited | FY2027 Q2 · Calendar Q4 2026 | — | — | ICICI Bank Q2 FY27: Strong Growth, Temporary Margin Pressure |
| HDB HDFC Bank Limited | FY2027 Q2 · Calendar Q4 2026 | — | — | HDFC Bank: Strong deposits, resilient asset quality, margins under pressure |
| MTB-PH M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.2% | — | M&T Bank: Loan Growth Holds Up as Rates Pressure Margins |
| MTB-PJ M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.2% | — | M&T: Deposit growth supports margins as AI use expands |
| RF-PE Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | +10.3% | — | Regions Financial: Fee Growth and Credit Quality Support Q3 |
| RF-PC Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | +10.3% | — | Regions Financial: Fee growth supports a steady Q3 outlook |
Latest beats and misses
Who reports nextBeat on EPS
Get the ARES recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-10-17T05:10:49.140638+00:00
- Polygon adjusted daily market bars · 2026-10-19T00:40:45.010606+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-19T00:40:45.006633+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-19. For educational purposes only; not investment advice.